Opportunity
SAM #CBER-2026-133470
FDA Seeks Maintenance Service Agreement for Zeiss LSM900 Confocal Imaging System
Buyer
Food and Drug Administration
Posted
March 26, 2026
Respond By
April 02, 2026
Identifier
CBER-2026-133470
NAICS
811210, 811219
The FDA's Center for Biologics Evaluation and Research (CBER) is seeking a comprehensive maintenance service agreement for its Carl Zeiss LSM900 confocal imaging microscope system at the White Oak FDA campus in Silver Spring, MD. - Government Buyer: - U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) - OEM Highlight: - Carl Zeiss is the Original Equipment Manufacturer (OEM) for the LSM900 confocal imaging system - Vendors Mentioned: - Carl Zeiss (as OEM and service provider) - Products/Services Requested: - Maintenance service agreement for Zeiss LSM900 confocal imaging system (serial number 2901000217) - Includes 12 months of technical support, preventive maintenance, unlimited emergency maintenance, and software updates - On-site repairs and maintenance for all system components (lasers, scan head, microscope objectives, control computer hardware/software) - Loaner parts provided within 5 business days if repairs cannot be completed on-site - Phone/email technical support within 24 hours; on-site engineer support within 72 hours - Scheduled and emergency repairs Monday-Friday, 8am-5pm (excluding federal holidays) - All travel, labor, and replacement parts included - Period of Performance: - Base period of 12 months with two additional 12-month option periods (total potential duration: 3 years) - Unique/Notable Requirements: - Service must be performed by Zeiss factory-trained engineers - Service delivery at FDA's Silver Spring, MD facility - Firm fixed price contract - No specific part numbers or product quantities beyond the single system are provided
Description
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) owns a Carl Zeiss LSM900 confocal imaging system (s/n 2901000217) for fluorescence microscopy. The current maintenance contract for this system expired in 2025. The Zeiss 900 imaging system is heavily used at White Oak FDA campus as a scientific tool in CBER’s research programs to support CBER investigators.
To minimize system downtime, CBER requires a service agreement for maintenance and possible repair.